Related Experiment Video
Updated: Jul 23, 2025

06:16
Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
Published on: April 19, 2024
1.0K
Systemic Review of Clot Retraction Modulators.
Alaina Guilbeau1, Rinku Majumder2
1LSUHSC School of Medicine, Public University, New Orleans, LA 70112, USA.
International Journal of Molecular Sciences
|July 14, 2023
Summary
Platelets shrink blood clots through clot retraction, a process vital for wound healing. Various compounds and physiological conditions can modulate this process, with ongoing research to fully understand the mechanisms involved.
Area of Science:
- Hematology
- Molecular Biology
- Pharmacology
Background:
- Platelets play a crucial role in hemostasis and wound healing through clot retraction, a process involving platelet shape change and thrombus stabilization.
- The molecular mechanisms underlying platelet activation and the subsequent actin remodeling during clot retraction are complex and not fully elucidated.
- Understanding clot retraction modulators is essential for developing therapeutic strategies targeting thrombosis and wound healing.
Purpose of the Study:
- To review current literature on substances and physiological conditions that modulate platelet clot retraction.
- To discuss specific compounds, including plant-derived substances and pharmaceutical agents, that influence clot retraction.
- To highlight the known and potential molecular targets and signaling pathways involved in clot retraction modulation.
Main Methods:
- Literature review of studies investigating clot retraction modulators.
- Analysis of research focusing on molecular signaling pathways, including protein phosphorylation and second messenger levels.
- Examination of the effects of various endogenous and exogenous compounds on platelet function and clot retraction.
Main Results:
- Several natural compounds (from Cudrania tricuspidata, Arctium lappa, Panax ginseng), caffeic acid, diindolylmethane, all-trans retinoic acid, MAP4K inhibitors, and Dasatinib diminish clot retraction.
- Endogenous Protein S (PS) and SMOC1 enhance clot retraction.
- Modulation of clot retraction involves complex signaling pathways, including changes in VASP, IP3R, phospholipases (PLA2, PLCγ2), JNK, PI3Ks, SFK, cAMP levels, and inflammatory markers (TXA2, PGE2, ROS, COX).
Conclusions:
- A diverse range of compounds and physiological states can significantly modulate platelet clot retraction.
- Further in-depth research is required to fully elucidate the mechanisms by which these modulators affect clot retraction and their therapeutic potential.
- Understanding these modulators may offer new avenues for treating bleeding disorders, thrombosis, and improving wound healing.

